Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -0.58% dropped 0.04% to $125.62 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.58% falling 0.25% to 11,148.64 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.45% falling 0.14% to 30,273.87. The stock's fall snapped a three-day winning streak. Moderna Inc. closed $251.03 short of its 52-week high ($376.65), which the company reached on November 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.75% rose 0.94% to $143.33, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.39% rose 0.34% to $233.82, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.06% fell 0.54% to $56.73. Trading volume (2.3 M) remained 2.6 million below its 50-day average volume of 4.8 M.